GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC


Idag, 04:00

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

PR Newswire

NEW YORK CITY and NEW ORLEANS, July 17, 2026

NEW YORK CITY and NEW ORLEANS , July 17, 2026 /PRNewswire/ -- - Kahn Swick & Foti , LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026  to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp.  (NasdaqGS: WGS) ("GeneDx" or the "Company"), if they purchased or otherwise acquired the Company's shares between April 16, 2025 and May 4, 2026, inclusive (the "Class Period").  This action is pending in the United States District Court for the District of Connecticut.

Läs mer på PR Newswire

Ämnen i artikeln

GeneDx

Senast

63,48

1 dag %

2,90%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån